HLF241213C8000
- 0.02
- -0.01-33.33%
Herbalife Newsroom
Citi Maintains Herbalife(HLF.US) With Buy Rating, Maintains Target Price $13
Herbalife Is Maintained at Neutral by Mizuho
Mizuho Securities Maintains Herbalife(HLF.US) With Hold Rating, Cuts Target Price to $9
DA Davidson Maintains Neutral on Herbalife, Lowers Price Target to $7.5
Herbalife Analyst Ratings
B.Riley Financial Maintains Herbalife(HLF.US) With Buy Rating, Cuts Target Price to $12
B. Riley Adjusts Herbalife's Price Target to $12 From $17, Maintains Buy Rating
Herbalife Analyst Ratings
Citi Maintains Herbalife(HLF.US) With Buy Rating, Cuts Target Price to $13
Herbalife's Digital Engagement and Market Trends Support Buy Rating Despite Lowered Target Price
Citi Maintains Herbalife(HLF.US) With Buy Rating, Maintains Target Price $16
Buy Rating Affirmed: Signs of Recovery in Web and App Traffic Indicate Strengthening Market Position for Herbalife
Citi Maintains Herbalife(HLF.US) With Buy Rating, Maintains Target Price $16
Buy Rating Affirmed: Herbalife's Positive Web Traffic and Share Price Return Outlook
BofA Securities Maintains Herbalife(HLF.US) With Sell Rating, Maintains Target Price $8
Herbalife Faces Sales Decline and Persisting Challenges: An Underperform Rating With a Price Objective of $8
Herbalife Analyst Ratings
B.Riley Financial Maintains Herbalife(HLF.US) With Buy Rating, Raises Target Price to $17
D.A. Davidson Maintains Herbalife(HLF.US) With Hold Rating, Announces Target Price $13
Hold Rating on Herbalife: Balancing Cost-Saving Success Against Revenue Shortfalls and Market Challenges